801-2, Jindong Mansion, No. 536 Xueshi Road, Yinzhou, Ningbo 315100, P.R.China
Home ProductsDry Powder Injection

0.5g / 1.0g Dry Powder Injection Ifosfamide , Anti Cancer Medication

0.5g / 1.0g Dry Powder Injection Ifosfamide , Anti Cancer Medication

0.5g / 1.0g Dry Powder Injection Ifosfamide , Anti Cancer Medication

Product Details:

Place of Origin: China
Brand Name: Newlystar
Certification: GMP
Model Number: 0.5g, 1.0g

Payment & Shipping Terms:

Minimum Order Quantity: 20000 vials
Price: Negotiation
Packaging Details: 10 vials/box
Delivery Time: 45days
Payment Terms: L/C, T/T
Supply Ability: 200, 000 vials per day
Contact Now
Detailed Product Description
Product: Ifosfamide For Injection Specification: 0.5g, 1.0g
Standard: BP, USP Packing: 10 Vials/box

0.5g / 1.0g Dry Powder Injection Ifosfamide , Anti Cancer Medication

 

 

Product : Ifosfamide for Injection

Specification : 0.5g, 1.0g

Standard : BP, USP

Packing : 10 vials/box

 

Description :

Ifosfamide is a chemotherapeutic agent chemically related to the nitrogen mustards and a synthetic analog of cyclophosphamide. It is active as an alkylating agent and an immunosuppresive agent.

 

Indication

Used as a component of various chemotherapeutic regimens as third-line therapy for recurrent or refractory germ cell testicular cancer. Also used as a component of various chemotherapeutic regimens for the treatment of cervical cancer, as well as in conjunction with surgery and/or radiation therapy in the treatment of various soft tissue sarcomas. Other indications include treatment of osteosarcoma, bladder cancer, ovarian cancer. small cell lung cancer, and non-Hodgkin's lymphoma.

 

Pharmacodynamics

Ifosfamide requires activation by microsomal liver enzymes to active metabolites in order to exert its cytotoxic effects. Activation occurs by hydroxylation at the ring carbon atom 4 to form the unstable intermediate 4-hydroxyifosfamide. This metabolite than rapidly degrades to the stable urinary metabolite 4-ketoifosfamide. The stable urinary metabolite, 4-carboxyifosfamide, is formed upon opening of the ring. These urinary metabolites have not been found to be cytotoxic. N, N-bis (2-chloroethyl)-phosphoric acid diamide (ifosphoramide) and acrolein are also found. The major urinary metabolites, dechloroethyl ifosfamide and dechloroethyl cyclophosphamide, are formed upon enzymatic oxidation of the chloroethyl side chains and subsequent dealkylation. It is the alkylated metabolites of ifosfamide that have been shown to interact with DNA. Ifosfamide is cycle-phase nonspecific.

 

Mechanism of action

The exact mechanism of ifosfamide has not been determined, but appears to be similar to other alkylating agents. Ifosfamide requires biotransformation in the liver by mixed-function oxidases (cytochrome P450 system) before it becomes active. After metabolic activation, active metabolites of ifosfamide alkylate or bind with many intracellular molecular structures, including nucleic acids. The cytotoxic action is primarily through the alkylation of DNA, done by attaching the N-7 position of guanine to its reactive electrophilic groups. The formation of inter and intra strand cross-links in the DNA results in cell death.

Contact Details
Newlystar (Ningbo) Medtech Co.,Ltd.

Contact Person: Luke Liu

Send your inquiry directly to us (0 / 3000)